At what enterprise value was ORKYN (EX LVL MEDICAL) acquired in 2012?

During the acquisition of ORKYN (EX LVL MEDICAL) by AIR LIQUIDE in 2012, the transaction's Enterprise Value is estimated to be in the range of 300M - 700M EUR.

What was the EV/EBITDA of ORKYN (EX LVL MEDICAL) when it was acquired by AIR LIQUIDE?

The estimated EV/EBITDA multiple for ORKYN (EX LVL MEDICAL) is in the range of 10x - 18x.

When was ORKYN (EX LVL MEDICAL) acquired by AIR LIQUIDE?

ORKYN (EX LVL MEDICAL) was acquired by AIR LIQUIDE in 2012.

What was the revenue of ORKYN (EX LVL MEDICAL) at the time of the deal?

The revenue of ORKYN (EX LVL MEDICAL) at the time of the deal is estimated to be in the range of 100M - 200M EUR.

What was the EBITDA of ORKYN (EX LVL MEDICAL) during the acquisition?

ORKYN (EX LVL MEDICAL)'s EBITDA is estimated to be in the range of 25M - 50M EUR.

How is the data for the ORKYN (EX LVL MEDICAL) acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the ORKYN (EX LVL MEDICAL) deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.airliquide.com/fr/groupe/communiques-presse-actualites/08-06-2012/projet-dacquisition-de-lvl-medical-acteur-majeur-de-la-sante-domicile-en-france

← DATABASE

Home Database Healthcare & PharmaORKYN (EX LVL MEDICAL)

06/2012

ORKYN (EX LVL MEDICAL) acquired by AIR LIQUIDE

FRANCE Health Providers / Outpatient Care EV 300M - 700M EUR

Context

Air Liquide entered into exclusive negotiations to acquire a controlling block of 70.49% of LVL Médical's share capital from the Lavorel family concert and other controlling shareholders. Simultaneously, the Lavorel family repurchased LVL Médical's German subsidiary for €80 million, such that Air Liquide's acquisition perimeter is limited to the French activities only. The transaction is subject to clearance from the French competition authority. Air Liquide intends to maintain continuity in LVL Médical's management.

ORKYN (EX LVL MEDICAL), which reported an EBITDA margin of in 2011, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Orkyn (ex LVL Medical) is a leading French home healthcare services provider, recognised as one of the historical and most established players in this segment in France. The company specialises in the management of chronic disease patients at home, providing medical equipment, respiratory therapy devices, and follow-up services on medical prescription. Its service offering covers key pathologies including chronic obstructive pulmonary disease (COPD), sleep apnoea, and diabetes — conditions that require long-term, recurring home-based medical monitoring and equipment. Orkyn had built a strong operational infrastructure across France, with a nationwide network enabling patient coverage in both urban and rural areas.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2011

2010

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
01/2015	CERBA HEALTHCARE	NOVESCIA	FRANCE	Labs (Biology)
10/2014	WATERLAND	MEDIAN KLINIKEN	GERMANY	Clinics / Hospitals
09/2014	EURAZEO	COLISÉE	FRANCE	Nursing Homes
06/2014	PAI PARTNERS	DOMUSVI	FRANCE	Nursing Homes
03/2014	EQT PARTNERS	I-MED RADIOLOGY NETWORK	AUSTRALIA	Radiology
07/2012	MANAGEMENT & PRIVATE INVESTORS	LVL MEDICAL GERMANY	GERMANY	Outpatient Care
12/2010	SAGA GROUP	NESTOR HEALTHCARE GROUP	UNITED KINGDOM	Outpatient Care
06/2010	PAI PARTNERS	CERBA HEALTHCARE	FRANCE	Labs (Biology)
05/2010	HG CAPITAL	FRÖSUNDA	SWEDEN	Healthcare Facilities
03/2010	BRIDGEPOINT	CARE UK	UNITED KINGDOM	Nursing Homes

REFERENCES

Valuation range: EV 300M - 700M EUR

Revenue range: 100M - 200M EUR

EBITDA range: 25M - 50M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of ORKYN (EX LVL MEDICAL) by AIR LIQUIDE are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Acquirer: air liquide